FinancialContent is the trusted provider of stock market information to the media industry.
More NewsRead More
Advaxis Provides Clinical Update for Phase 1/2 Trial of ADXS-HPV Immunotherapy Product Candidate in Anal Cancer
October 15, 2014
Advaxis's Lm-LLO Immunotherapy Data to be Presented in Three Posters at the Society for Immunotherapy of Cancer 29th Annual Meeting
October 14, 2014
Advaxis Appoints World Renowned Oncologist and Research Scientist, Dr. Samir N. Khleif, to Its Board of Directors
October 08, 2014
Advaxis's Chief Scientific Officer, Dr. Robert Petit, Leads Panel Discussion on Combination Immunotherapies
October 01, 2014
Advaxis's Cancer Immunotherapy Featured on Fox News
September 26, 2014
Markets climb as S&P 500 tops 2000
August 25, 2014
category Market News
Advaxis, Inc. “Changing Seasons – but not direction. Where’s Advaxis headed as summer becomes fall?”
September 22, 2014
Advaxis Provides a Clinical Development Update for Its Immunotherapy, ADXS-HPV, for the Treatment of Cervical Cancer
September 09, 2014
Advaxis to Present at Upcoming Investor Conferences
September 08, 2014
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here